| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | Biomarker | disease | BEFREE | The role of PD-L1 in thyroid cancers has not been well defined in fine-needle aspiration cytology (FNAC). | 31821747 | 2020 | ||||
|
0.090 | Biomarker | disease | BEFREE | Then, we will evaluate the available data indicating the PD-1/PD-L1 axis as a promising target for thyroid cancer therapy. | 30897754 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | Soluble PD-L1 may provide clinicians with a non-invasive biomarker that can lessen dependence on tissue biopsies and diagnose aggressive thyroid cancers at a more treatable stage. | 31252406 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | We found that approximately 70-90% of ATC cases were positive for PD-L1 whereas normal thyroid and differentiated TC were negative. | 30762153 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | PD-L1 checkpoint pathway blockade may emerge as a promising therapeutic target in the treatment of thyroid cancers. | 30913016 | 2019 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions. | 29731981 | 2018 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | The results confirm the prognostic significance of PD-L1 expression in thyroid cancer patients. | 29455638 | 2018 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | We evaluated the PD-L1 expression in various thyroid cancers on a large scale. | 28093480 | 2017 | ||||
|
0.090 | Biomarker | disease | BEFREE | We investigated the role of PD-L1 in thyroid cancer with respect to BRAF mutation and MAP kinase pathway activity and the effect of anti PD-L1 antibody therapy on tumor regression and intra-tumoral immune response alone or in combination with BRAF inhibitor (BRAFi). | 26943572 | 2016 |